We are looking forward to taking part in Oribiotech's event in California on the 12th October 2023
Ori Biotech is partnering with Alliance for Regenerative Medicine (ARM) to run a strategic session focusing on navigating the ever-evolving landscape of digital and data in cell and gene therapy.
As an industry we all agree that for CGT to have widespread impact for a consistently expanding patient base, a digital backbone is indispensable. Relying solely on paper-based systems introduces too many constraints, especially in the manufacturing process.
The session will bring together key decision-makers across the CGT industry to delve into pressing questions:
- What are the primary pain points and barriers in adopting digitally native approaches, especially in the early, preclinical stages of the development process?
- What are the compelling use cases in preclinical stages that support the need for prioritization of a digital approach right from the start?
Together, we will pinpoint the challenges and explore digital solutions, always keeping the end goal in sight.
Our speakers:
Stephen Ward, Chief Manufacturing Officer, will be taking part in this event.